Amazon (AMZN) is down 18%.

Microsoft (MSFT) has dropped 24%.

Silver has fallen 30%.

Salesforce (CRM) and other software stocks are at 52-week lows.

And bitcoin has plunged 44% from its recent highs.

There are plenty of folks who loaded up on these popular investments and are feeling the pain right now. They probably think the good times are over – that this bull run is all but done for.

They're wrong.

Sure, some of the biggest stocks are down. But this is mostly because they were priced near perfection. We're simply seeing a lot of stocks and assets take a breather after a huge run higher in 2025. (Software is another story – the market is worried this sector will lose pricing power because of artificial intelligence ["AI"].)

But I need to pound the table once again...

This is a healthy market.

And overall, most stocks are doing great.

For example, the S&P 500 Equal Weight Index is breaking out...

We can also gauge the health of the market by looking at the "advance/decline" line.

Regular readers are familiar with this measure... You take the number of stocks that went up on a given day and subtract the number that went down. If more went up that day, the line goes up. If more went down, the line goes down.

In a typical bull market, as the market goes up, the advance/decline line goes up, too. When the advance/decline line moves lower while the market continues to go up, then it's time to worry. It means the gains are concentrated in only a few companies.

We're not seeing that today. In fact, the advance/decline line for all stocks on the New York Stock Exchange ("NYSE") is at a fresh all-time high.

Last week, I told you that nearly 70% of NYSE stocks were trading above their 200-day moving averages (200-DMAs). When this happened in the past, the S&P 500 Index was up an average of 19% one year later.

It's an incredibly bullish signal.

Here's another data point that shows the same thing...

Right now, 19% of S&P 500 stocks are at 52-week highs.

In past instances like this, the S&P 500 was higher six to 12 months later... every time.

The average gain six months after this occurs is 8.6%. And the average gain one year later is 16.2%. Take a look...

I don't want to sound like a broken record. But you need to keep your money in stocks this year...

Even though market valuations are stretched, there are plenty of buying opportunities.

One of my favorite buys today is actually in the beaten-down software sector.

The market is convinced that AI will disrupt this business. But recent results prove that's not even close to accurate. Still, Mr. Market is ignoring all the glaring signs that AI is actually going to help this business.

This is one of the most profitable companies in the world. And it's trading at a 15-year low valuation.

It's one of the best buys I've seen in a long time.

Retirement Millionaire subscribers can read about this company, which we added to our portfolio last year, by clicking here.

If you aren't already subscribed to Retirement Millionaire, you can click here to learn more about signing up.

(Our next issue of Retirement Millionaire publishes later tonight... In it, we're recommending one of the best dividend-paying stocks out there that's also trading near a decade-low valuation.)

Like I said, there are plenty of great buying opportunities to take advantage of in this raging bull market.

What We're Reading... 

Here's to our health, wealth, and a great retirement,

Jeff Havenstein
February 11, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top